Razuprotafib
Razuprotafib is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target receptor-type tyrosine-protein phosphatase beta.
| Trade Name | |
|---|---|
| Common Name | Razuprotafib |
| Indication | |
| Drug Class | Protein tyrosine phosphatase 1B inhibitors |
